captan has been researched along with amphotericin b in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamann, MT; Kasanah, N; Shilabin, AG; Wedge, DE | 1 |
| Mafakheri, H; Mirghazanfari, SM | 1 |
2 other study(ies) available for captan and amphotericin b
| Article | Year |
|---|---|
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
Topics: Antifungal Agents; Antineoplastic Agents; Antiparasitic Agents; Cell Line, Tumor; Depsipeptides; Drug Screening Assays, Antitumor; Fusarium; Humans; Lysosomes; Microbiological Techniques; Mycobacterium tuberculosis; Opportunistic Infections; Parasitic Sensitivity Tests; Receptor, ErbB-3; Structure-Activity Relationship | 2007 |
Antifungal activity of the essential oils of some medicinal plants against human and plant fungal pathogens.
Topics: Amphotericin B; Antifungal Agents; Captan; Fungi; Humans; Microbial Sensitivity Tests; Oils, Volatile; Plants, Medicinal | 2018 |